NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Patients with Type 2 Diabetes
Date of first enrollment	03/03/2010
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : CS-1036 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Postprandial glucose
Secondary Outcome	1. Fasting plasma glucose, insulin, glycoalbumin, and 1,5-anhydroglucitol 2. Safety and tolerability

Key inclusion & exclusion criteria

Age minimum	>= 70age old
Age maximum	<= 20age old
Gender	Both
Include criteria	1. Patients diagnosed with type 2 diabetes mellitus 2. Outpatient
Exclude criteria	1. Patient with type 1 diabetes mellitus 2. Patient with clinically significant diabetic complications